Literature DB >> 17592563

Banding hemorrhoids using the O'Regan Disposable Bander. Single center experience.

Dimitrios Paikos1, Anthie Gatopoulou, John Moschos, Anastasios Koulaouzidis, Shivram Bhat, Dimitrios Tzilves, Konstantinos Soufleris, Dimitrios Tragiannidis, Ioannis Katsos, Anestis Tarpagos.   

Abstract

BACKGROUND: Hemorrhoids are the most common anorectal disorder in the Western World and are a major cause of active, relapsing or chronic rectal bleeding. Many treatment options have been proposed and tried for early-stage hemorrhoids. There is general agreement that rubber banding ligation (RBL) is safe and effective. AIMS: To evaluate the effectiveness and complications associated with RBL performed in outpatients for symptomatic hemorrhoids using the O'Regan Disposable Bander device.
RESULTS: Sixty consecutive patients underwent hemorrhoid banding with the O'Regan Disposable Bander. The mean time required for one session was 6.2 min; the longest was 10 min. No major complications were noted. Minor early and late bleeding was reported in 10% and 6.7% respectively, but none was severe. Pain occurred in 6.7% but was not severe. In all cases, clinical and endoscopic (range and form scores) improvement was observed and patients of all ages, including the elderly, were found to be tolerant to the procedure.
CONCLUSION: RBL performed in outpatients for symptomatic hemorrhoids using the O'Regan Disposable Bander device is associated with a good response and low complication rate. We recommend the technique as a safe and reliable treatment option.

Entities:  

Mesh:

Year:  2007        PMID: 17592563

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN: 1841-8724            Impact factor:   2.008


  1 in total

1.  Massive gastrointestinal bleeding after endoscopic rubber band ligation of internal hemorrhoids: A case report.

Authors:  Yu-Dong Jiang; Ying Liu; Jian-Di Wu; Gang-Ping Li; Jun Liu; Xiao-Hua Hou; Jun Song
Journal:  World J Clin Cases       Date:  2022-07-06       Impact factor: 1.534

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.